-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R0+kKMTuSk//5IzX0AU+mka3e9P9Su5XWJjqhswDYcgOo45VrPbfYdxm3nG+S9ci FPLpCALjfL937rN2iS+W3g== 0001144204-09-000136.txt : 20090102 0001144204-09-000136.hdr.sgml : 20090101 20090102172053 ACCESSION NUMBER: 0001144204-09-000136 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20081226 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20090102 DATE AS OF CHANGE: 20090102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE GENETICS INC CENTRAL INDEX KEY: 0001124608 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33509 FILM NUMBER: 09502083 BUSINESS ADDRESS: STREET 1: 1640 MARENGO ST., STREET 2: 6TH FLOOR CITY: LOS ANGELES, STATE: CA ZIP: 90033 BUSINESS PHONE: (323) 224-3900 MAIL ADDRESS: STREET 1: 1640 MARENGO ST., STREET 2: 6TH FLOOR CITY: LOS ANGELES, STATE: CA ZIP: 90033 8-K 1 v135991_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
 

 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
December 26, 2008
 

 
RESPONSE GENETICS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
000-1124608
 
11-3525548
(State or other jurisdiction of
incorporation or organization)
 
(Commission
File Number)
 
(IRS employer
identification no.)
 
1640 Marengo St., 6th Floor
Los Angeles, California 90033
(323) 224-3900
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 1.01.  Entry into a Material Definitive Agreement.
 
On December 26, 2008, Response Genetics, Inc. (the “Company” or “RGI”) amended and restated its master service agreement with GlaxoSmith Kline, Ltd. (“GSK”), a leading pharmaceutical manufacturer (the “GSK Agreement”).  Pursuant to the amendment, the term of the GSK Agreement has been extended for a two-year period, with the option for the parties to extend the GSK Agreement for additional one-year periods, upon their mutual written agreement.  In addition, RGI will become a preferred provider to GSK and its affiliates of genetic testing services on a fee-for-service basis and, in anticipation of the services to be provided, GSK agreed to make a non-refundable upfront payment of $1,300,000 to the Company on or before December 31, 2008.  This payment may be credited against future work undertaken in the period beginning on January 1, 2009 and ending on December 31, 2010.

A copy of the press release announcing the amendment of the GSK Agreement is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01.  Financial Statements and Exhibits.

(d) The following exhibit is furnished with this report:
 
 
Exhibit Number
Description
 
99.1
Press Release, dated January 2, 2009.
 
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
RESPONSE GENETICS, INC.
     
     
Dated: January 2, 2009
By:
/s/ Thomas Stankovich
 
   
Thomas Stankovich
Vice President and Chief Financial Officer


 
 

 
EX-99.1 2 v135991_ex99-1.htm
Exhibit 99.1

 
FOR IMMEDIATE RELEASE

Investor Relations Contact:
Media Relations Contact:
Peter Rahmer
Barry Sudbeck
Trout Group
Fleishman-Hillard
646-378-2973
415-318-4261

Response Genetics Signs Amendment to its Master Service Agreement With GlaxoSmithKline
as Preferred Provider of Genetic Testing Services

LOS ANGELES, January 2, 2009 – Response Genetics, Inc. (Nasdaq: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, announced today it has signed an amended and restated master service agreement with GlaxoSmithKline, Ltd. (NYSE: GSK).  This agreement extends the current agreement between the companies for a two-year period and names Response Genetics as preferred provider of genetic testing services to GlaxoSmithKline and its affiliated companies. In anticipation of 2009 services, GlaxoSmithKline agreed to make an upfront payment to Response Genetics of $1.3 million before the end of 2008.

“We are very pleased to continue supporting GlaxoSmithKline’s clinical trial development program,” said Kathleen Danenberg, Response Genetics’ president and CEO. “Our collaborative relationship underscores the value our service and patented technology brings to pharmaceutical partners like GlaxoSmithKline, in helping them develop new cancer-fighting therapies.”

Response Genetics’ patented diagnostic technology and services are also commercially available to physicians through the company’s ResponseDX: Lung™ and ResponseDX: Colon™ tests.  By providing information on a panel of molecular markers, these PCR-based genetic tests can help physicians with therapeutic treatment decisions in patients with non-small cell lung cancer and colorectal cancer.

About Response Genetics, Inc.

Response Genetics, Inc. (“RGI”) (the “Company”) (Nasdaq: RGDX) is engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies. RGI’s technologies enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. In addition to diagnostic testing services, RGI generates revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. The Company was founded in 1999 and its principal headquarters are located in Los Angeles, California. For more information, please visit www.responsegenetics.com.

 
Page 1 of 2

 
 
Forward-Looking Statement Notice

Except for the historical information contained herein, this press release and the statements of representatives of RGI related thereto contain or may contain, among other things, certain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995.

Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the Company’s plans, objectives, projections, expectations and intentions, such as the ability of the Company to analyze cancer samples, the potential for using the results of this research to develop diagnostic tests for cancer, the usefulness of genetic information to tailor treatment to patients, the ability of the parties to fulfill the terms of the Amended and Restated Master Service Agreement, the ability of the Company to expand its ResponseDX: Lung™ and ResponseDX: Colon™ test availability, and other statements identified by words such as “projects,” “may,” “could,” “would,” “should,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans” or similar expressions.

These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties, including those detailed in the Company’s filings with the Securities and Exchange Commission. Actual results, including, without limitation, actual sales results, if any, or the application of funds, may differ from those set forth in the forward-looking statements. These forward-looking statements involve certain risks and uncertainties that are subject to change based on various factors (many of which are beyond the Company’s control). The Company undertakes no obligation to publicly update forward-looking statements, whether because of new information, future events or otherwise, except as required by law.

###
 
 
Page 2 of 2

 
GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!`@$`2`!(``#_X1)!17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(```` M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`P.#HQ,CHS M,2`Q,3HR,3HS-````````Z`!``,````!__\``*`"``0````!````J:`#``0` M```!````1@`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$``!$+```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B M95]#30`"_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`0@"@`P$B``(1`0,1`?_=``0` M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]522224I))))2DDDDE*6#]8?K?@=$?\` M9@PY6:6[A0QP:&C\UV19[O2:_P#,VUVV?\&MK(^T?9[?LH87VWWBIGJ64GTO4POMN1TI[\=]7Z#U<6W M^C>E_P`&K_PWE<6:BU_Z>OU'O\`T7^%_MK=GS/+\N,4 M(P$8Y2(4*CPQ[_ZSA_2X'-'+Y\IF93LP]0U_2_\`4;S72/KKUKIIV6O^WT:S M7D.)>/I']'E_I+6^]W^&;D>QGIU>BN^Z'U_I_7,=]V&2UU3MMU+X%C#KLWAC MGM_2-&YFQ_\`X(RQ>:XN%TXUGUWM>;6>R_[5BUMK+F_3.#;EXN7:^NS^;]>_ M$]EGZQA?HO16GT7/^L5G7\6BEC:;F@,R*&T&MM6/[?T.50[[/LKH8W[1B>__ M`+5_HK/UJRA5>?Y+!EC.6.,<>2`,Y3O@C4?WH1XO_4DS)HKML+'*/RX.(YCZJC&<_3']W_6? M]3:V8@$Q.^32`_NNUG=)Z7U+H^._J9#*L:@O-QVC8UU+JK7[[&OV-K:_[1_Q M]%%O^"0,R^V[ZM]+NSR?T[L+[=O&UI%IK;D-R*X;7Z5CK-EM;V^DJ/7\VRVS M!^K->2W"==CV'J%[X>VNL8]H=5:T65M^@++/YQGI_H+U3S/K/F=1Q[';=:["]7*LW,;[[M^_TM_V/]%ZM?](]-^+E\LAB-W'C]R() M]4,4YRA'VOWI9O7/T_YK_9HEDA4AUKA-=91C^E_=^5[+`JQZ,9N-C5NIIQR: MF,>'"`TQ[/4]SJO]&N6<,(?5.FS[.[[7=TRK$^T%I@,JQOVB!O=_@'2^O?5] M/*_16?S7Z/>Z!U$Y>,_&O?.;A.-60UWTR`3]FRB/H[,RAOKLLK_1?3]_Z)ZY MC'ZU3DO/U4;D,=AG$JP,;-:PN:_(K;LLN#6G^9N_FV?I/\!ZGJ^G14Y[B?S6,8\N`=6DLL>UWN24WTE19USHMF%9GU]0QGX5+MEN M4VZLU-<=OLLO#_28_P#25_G?X1#?]9/J[757=9U7#95=/I6.R*@U^T[7^F\O MVOV.^GM24Z22#]KQ?LOVWUJ_LGI^M]HW#T_3CU/6]6?3]+T_?ZGT-BH=*^M/ MU>ZQD78O3,^K)OH<6OK:8)VF'/JWAOKT_P##T>I3_P`(DITW&O;OI MO8ZNULD2UXV/;N;M=]$KRWZT?5RWH>5H'6=/M@49#R"=VT;ZKW-;6QEN_>^O MV>^K_B[5Z=A=0P,^MUN!DU9=3'%CGT/;8T/`#G5N=47-W[7-]J"[J?1;J\G? MEXUE6$Z,N;*W-IS_"JYR//3Y6=@<6.7SPNO\*/]9@YGEHYH MT=)#Y9/E^([&P>F76V,/VS/#Z,5VUI-=`;%^0QEKO>W/?9^S_5]/]#35F68] MWJ?J]VA3Z%?1F7^H]ME?37&QK=!O^W6?L>RNQGZ2M]>I= MAO=NM?#GFAY-E7NL+[OT639D>L^OTJ?3MPJK_4_0+<^IGU5'4'#J6*SZ=@H?OV/]%WL? MZ?\`-JOS?Q:/!+%RUCB-G)\M<7JF(A=AY(\49YB"8BN'<:;%T4EFM^LOU_?M8ZST[-G]17,K+Q<*AV3F75XV/7&^ZUP8Q MLD,;NLL+6-W/=M6*Z"9)9M_UE^KF/8:LCJN'38`UQ99D5-=#@+*W;7/W>^MS M7L0_^=GU5_\`+G`_]BJ?_2B2G6253&ZOTK,]/[)FX^1ZV_TO2M8_?Z>WUO3V M.=O]+>SU=O\`-H67]8>@85[L;,ZEB8U[(WTW7UL>)&YNZNQ[7MW-*2G025"_ MKW0\;*.%D=1Q:',=958*\?T;*[:7O:UEEU&RRO?\`\)_HGH8Q_P#&-1]9 MG?62GH53\G)PJ\:^K[17Z8=^C=8]LVTV5^^C^9_3[/\`36I*:/7\KZO=2Q>D M]:Q/J_:/J]@9>31U/$96S&<'W,P_2R/3P[/=^;M>YS&6V4_9;;*O5J5OJ%GU M7S_K;]6KL*O%/U?=1ENFV]V0^W'O9777L=7ZC_4K_5Z0S*S^H5_5WI[0_ZJ=5ZU9935N=67TXNRW(K+W/KR?2^P68MFR_] M)Z^/3Z.S(]5=G]MI?;0[]'G=/JS\C(S6UL:^QC0['J9:/M?\`/5^EZUCZO28Y M_J?SGJ5,_1I*1_6/J_U2ROJOT?.Z/B5CIU?6<9^9T^JFMMAVUW^K3?BM_1VW M74LV>]^R[_2+H/J;U[ZJ=3ZE=3T3HCNEY+*"^R]V+3CRS>QOI>ICO>]VY^U^ MS_@US]OU-^M%&)^VJ,.NSK&7UC'ZG9TUCV-KJ9CC+L:QUSWL8]S[NM M^K74_KIEYME?U@Z35T_%%1=7;58UY-FYH],M9==_@R]WT?S$E.+T+#POKUU7 M/ZSUG=E8G3W)NN^A8RS]!_P`;7Z->-A_7C+^J M]/5.A'I^'6_`P.H9=/4,+'QVM#[JC@MR:OL[FU59#W,]-G[EG[ZZC+Z']9_J M_G9O4_JN:L^CJ#G7Y/2L@BL"]SV?I\-[/29_-'],VVRK^:_P]OI>GRCOJS]> M1?A]6;TD'.JZOF]2LQO6J#`+Q@/K;ZGK?0=91>SZ6_\`1I*0_6[K/U*F-QZLC8 M1BXVYVW(_Q?9&+DX3:NMY)9NPJWMVC9E,>W;:^UU7]%J]7^>24T/K6VKH M'4Z[^CTU81P^E9^11756UM8M+L6IUOHL#:W/V_\`45[U8^IGU*^K]O1L/K'4 ML6OJ?4^H4"_)RI5N;5Z[*_4L_P"NV+0Z]T&_JOUAQ?5J M<[IEF!EXF7:TM&WUO3],!KSOW^S?6_T_IK'PZ/\`&7]6<&OI>'C8O7<6ESV8 MUQL].QE+-K:&6LM?0WZ/\VQMN1Z7\UZGI^BDIR_JN_]'_A/1J7J2\]R.F?77ZUY6'1 MU[I6'TO'PK1DC+EMUAVEI^R4^E?8]GVG:WUOY%?_`!==EVU_^,BKKF*VD"_I M-F4?M3G-QVFO&&396S:YKV6V>ITYM5_\UZGZ3]])3__3]527RJDDI^JDE\JI M)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI)*?J MI)?*J22GZJ27RJDDI__9_^T6_E!H;W1O.$))30/S```````)```````````!`#A"24T$"@`````` M`0``.$))32<0```````*``$``````````CA"24T#]0``````2``O9F8``0!L M9F8`!@```````0`O9F8``0"AF9H`!@```````0`R`````0!:````!@`````` M`0`U`````0`M````!@```````3A"24T#^```````<```________________ M_____________P/H`````/____________________________\#Z`````#_ M____________________________`^@`````________________________ M_____P/H```X0DE-!`````````(``3A"24T$`@``````!``````X0DE-!`@` M`````!`````!```"0````D``````.$))300>```````$`````#A"24T$&@`` M```#/0````8``````````````$8```"I````!`!L`&\`9P!O`````0`````` M```````````````````!``````````````"I````1@`````````````````` M```!`````````````````````````!`````!````````;G5L;`````(````& M8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P`````` M````3&5F=&QO;F<``````````$)T;VUL;VYG````1@````!29VAT;&]N9P`` M`*D````&7!E`````$YO;F4````)=&]P3W5T\```!$+`!@``?_8_^``$$I&248``0(!`$@` M2```_^T`#$%D;V)E7T--``+_[@`.061O8F4`9(`````!_]L`A``,"`@("0@, M"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P, M#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!"`*`#`2(` M`A$!`Q$!_]T`!``*_\0!/P```04!`0$!`0$``````````P`!`@0%!@<("0H+ M`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,, M,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E M]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`" M$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:& MEJ:VQM;F]B7I[?'_]H`#`,!``(1`Q$`/P#U5))))2DDDDE*2222 M4I8/UA^M^!T1_P!F##E9I;N%#'!H:/S79%GN])K_`,S;7;9_P:VLC[1]GM^R MAAR-CO1%LAF^/T?J[/?Z>_Z>Q>7W8O5G9N53UAPK%UY?;?>*F>I92?2]3"^V MY'2GOQWU?H/5Q;?Z-Z7_``:O_#>5Q9IREFD.#'^AQ<,I_P#H+7YG+.``@#Q2 M_2KBC'S0]0^L_7,_).0_+LQ]`UM.,]]5;0/Y#+/>_P#>LL_\]_HUEU6NJL#Z M7FNVO5KF.+7-/BUS(C^DLSEV?5/JYN^J5.&]F)BY>&&.=>YQ;4W8?UB[[1Z+7_IZ_4>_P#1 M?X7^VMV?,\ORXQ0C`1CE(A0J/#'O_K.']+@0XEX^D?T>7^DM;[W?X9N1[&>G5Z*[[H?7^G]&.>W](T;F;'_P#@C+%YKBX73C6?7>UYM9[+_M6+6VLN;],X M-N7BY=KZ[/YOU[\3V6?K&%^B]%:?1<_ZQ6=?Q:*6-IN:`S(H;0:VU8_M_0Y5 M#OL^RNAC?M&)[_\`M7^BL_6K*%5Y_DL&6,Y8XQQY(`SE.^"-1_>A'B_]1S;' M+9LV/A&0F<9:1%<4O\=])2227.NDI))))2DDDDE*22224__0]522224I)))) M2DDDDE//?78`],KG_NU_[8=12ZZVG[$=C*_5R+-U;\AWT/\&M+E@9XLH7OA[:ZQCVAU5K196WZ`LL_G&>G^@O5/ M,^L^9U'%RJ/W(@GU0Q3G*$?:_>EF]<_3_FO]FB62%2'6N$UUE&/Z7]WY7LL" MK'HQFXV-6ZFG')J8QX<(#3'L]3W.J_T:Y9PPA]4Z;/L[OM=W3*L3[06F`RK& M_:(&]W^`=+Z]]7T\K]%9_-?H][H'43EXS\:]\YN$XU9#7?3(!/V;*(^CLS*& M^NRRO]%]/W_HGKF,?K5.2\_51N0QV&<2K`QLUK"YK\BMNRRX-:?YF[^;9^D_ MP'J>KZ=R9RV+(,F721]N4,N0W+^;CQ?K+_RGS>[P_P"43FG'@B+`XP81'];] MW^J]VDDDLULJ22224I))))2DDDDE/__1]526;1]9?J[DW,HQ^JX=UUAVUU5Y M%3GN)_-8QCRYRGE]?Z%@WG'S>I8F+>T`FJZ^NMX!U:2RQ[7>Y)3?25%G7.BV M85F?7U#&?A4NV6Y3;JS4UQV^RR\/])C_`-)7^=_A$-_UD^KM=5=UG5<-E5T^ ME8[(J#7[3M?Z;R_:_8[Z>U)3I)(/VO%^R_;?6K^R>GZWVC&^O3_`,/1ZE/_``B2 MG1R<>G*Q[<:]N^F]CJ[6R1+7C8]NYNUWT2O+?K1]7+>AY6@=9T^V!1D/()W; M1OJOQ[/\*KG(\]/E9V!Q8Y?/ M"Z_PH_UF#F>6CFC1TD/ED^7XCL;!Z9=;8P_;,\/HQ7;6DUT!L7Y#&6N][<]] MG[/]7T_T--699CW>I^KW:%/H5]&9?ZCVV5]-<;&MT&_[=9^Q[*[&?I*WUYSK MKG[7_P""J]7V?SFKU+H7U1S*[.IT]Z?EFG&&.:,5C7Q2'%WKNKJRG_K'K7/N^TV?] MJ;/46L?B'*9`)'*82,QDF)1G^CZ1C^6?R_\`I7]:U(\MF@2!$$"/!"CX\4IR M>>ORG9?2ZZ[1ZEV&]VZU\.>:'DV5>ZPON_19-F1ZSZ_2I].W"JO]3]`MSZF? M54=0<.I9S7-Q:G-=C,(:6W$'W.>VP/W4-C]W])^_^C6U1]5OJU]7WG.ZCF`4 MO+:ZSFV5U5;@[UVM_P`!7<_=2Q^RS_1+:=U_ZO8^+1<[J.'3BWAPQK#?4VMX MK/IV"A^_8_T7>Q_I_P`VJ_-_%H\$L7+6.(VJ8B%V'DCQ1GF()B*X=Q MIL7126:WZR_5Q]+[V]5PG4U%K;+1D5%K7/W>FU[]^UCK/3LV?U%Q#_YV?57_P`N<#_V*I_]*)*=9)5,;J_2LST_LF;CY'K; M_2]*UC]_I[?6]/8YV_TM[/5V_P`VA9?UAZ!A7NQLSJ6)C7LC?3=?6QXD;F[J M['M>W/\`8NL49C\SI=X]K6674;+*]_P#P MG^B>AC'_`,8U'UF=]9*>A5/R]E==>QU?J/ M]2O]RQ:XZ]_C5D3]7,:/^/K_`/>I4&?4/J3NJ]"HZC@T9/3L=V;;G"AP&.S[ M0^VZBBNJPTWO94[TO\"DIY7I#,K/ZA7]7>GM#_JIU7K5EE-6YU9?3B[+YK;+O1#_`-/?ONW_`.&K_G%I_6GZENR\+I3OJ^VG%S.@W-NP:K)% M.V6/LK?LW>YUE--OJ?\`I7U%3R,/ZY?6CJW3J^J8+.C]%P'U9>34ZRN]V1=6 M=_H_HG._0_F>F_\`X2V[U;/0JK2GD/\`%MU5_0\YW4[R*N@=6R+,*ZUVC:;Z MFLR<*W(L]-^QECOO_`*,HYV/;D4?65U=-F3CX_P!81=U&JF=S ML4/RPX'8YCK&>IM_._1_SW_"+M/J+]5IEH^U M_P`]7Z7K6/J])CG^I_.>I4S]&DI']8^K_5+*^J_1\[H^)6.G5]9QGYG3ZJ:V MV';7?ZM-^*W]';==2S9[W[+O](N@^IO7OJIU/J5U/1.B.Z7DLH+[+W8M./+- M[&^EZF.][W;G[7[/^#7/V_4WZT48G[:HPZ[.L9?6,?J=G36/8VNIF.,NQK'7 M/>QCW/MR?TNQZZWZM=3^NF7FV5_6#I-73\45%U=M5C7DV;FCTRUEUW^#+W?1 M_,24XO0L/"^O75<_K/6=V5B=-RG8O3>G/&VFL,].UV1,OZKT]4Z$>GX=;\#`ZAET]0PL?':T/NJ."W)J^SN;55D/M]!UE%[/I;_P!& MDI#];NL_5SJOU3RAT+I9Z3]GR\5V2UU%6.;`]N6VG3&<_P!7T_3L_G%=ZIU. MYG^+CJ_U8ZHYK.K]#-..6<&W&9D8S<3+H:ZNG=C^GLH_PC_95=?_`$E6_K+A M?7_ZT?5Z_#S^CUXU].1CVXM=-M9WC;DMR7/>_(>S]'-'M_E_YFW_`(R/J8?K M)TP9&$S=U;#!^S"6M]1CBWU:+'O_`)/OI]W\Y_QJ2GC*NK=`Z9]:NH/ZWTMW M5:[,/IXJ8W'JR-A&+C;G;W:-F4Q[=MK[75?T M6KU?YY)30^M;:N@=3KOZ/35A'#Z5GY%%=5;6UBTNQ:G6^BP-K<_;_P!17O5C MZF?4KZOV]&P^L=2Q:^I]3ZA0+\G)R@;=QO/VG6C(??1ZE6YM7KLK]2S_`*[8 MM#KW0;^J_6'%]6ISNF68&7B9=K2T;?6]/TP&O._?[-];_3^FL?#H_P`9?U9P M:^EX>-B]=Q:7/9C7&ST[&4LVMH9:RU]#?H_S;&VY'I?S7J>GZ*2G+^IS>B87 M7,OI'UNP:W?6/.R[;ZLW*H::;O>6UG"=>UOI_:,AN390ZO&QZ[_T?^$]&I>I M+SW(Z9]=?K7E8='7NE8?2\?"M&2,N6W6':6G[)3Z5]CV?:=K?6_D5_\`%UV7 M;7_XR*NN8K:0+^DV91^U.G)E4WI.5&-Z:V,Y M9"<_/@H\>#IX;7!M971A('AM;&YS.G@])V%D;V)E.FYS.FUE=&$O)R!X.GAM M<'1K/2=835`@=&]O;&MI="`S+C`M,C@L(&9R86UE=V]R:R`Q+C8G/@H\&EF/2=H='1P.B\O;G,N861O8F4N8V]M+V5X:68O,2XP+R<^"B`@/&5X M:68Z0V]L;W)3<&%C93XT,CDT.38W,CDU/"]E>&EF.D-O;&]R4W!A8V4^"B`@ M/&5X:68Z4&EX96Q81&EM96YS:6]N/C$V.3PO97AI9CI0:7AE;%A$:6UE;G-I M;VX^"B`@/&5X:68Z4&EX96Q91&EM96YS:6]N/C

&EF.E!I>&5L641I M;65N&UL;G,Z=&EF9CTG:'1T<#HO M+VYS+F%D;V)E+F-O;2]T:69F+S$N,"\G/@H@(#QT:69F.D]R:65N=&%T:6]N M/C$\+W1I9F8Z3W)I96YT871I;VX^"B`@/'1I9F8Z6%)E&UL;G,Z>&%P/2=H='1P.B\O M;G,N861O8F4N8V]M+WAA<"\Q+C`O)SX*("`\>&%P.D-R96%T941A=&4^,C`P M."TQ,BTS,50Q,3HR,3HS-"TP-3HP,#PO>&%P.D-R96%T941A=&4^"B`@/'AA M<#I-;V1I9GE$871E/C(P,#@M,3(M,S%4,3$Z,C$Z,S0M,#4Z,#`\+WAA<#I- M;V1I9GE$871E/@H@(#QX87`Z365T861A=&%$871E/C(P,#@M,3(M,S%4,3$Z M,C$Z,S0M,#4Z,#`\+WAA<#I-971A9&%T841A=&4^"B`@/'AA<#I#&%P.D-R96%T;W)4 M;V]L/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C&%P34TZ1&5R:79E M9$9R;VT@&UL;G,Z9&,])VAT='`Z+R]P=7)L M+F]R9R]D8R]E;&5M96YT&UP;65T83X*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0])W$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$ ME$5&I+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>G MM\?7Y_(B8J+C(V.CX*3E)66EYB9FING MM\?7Y_(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ M_]H`#`,!``(1`Q$`/P#U3BKL5=BKL5=BKL5=BJ%U35-/TG3Y]1U&=;:RMEYS M3/T`Z#8;LS'X55?B=OA7XLMP8)Y9B$!Q3E],6&3)&$3*1J(>$^=?^<@-0U"" M:P\MV[:=;2J4:_F/^E48+7TU0E(&'[Q.7*5N/%T]&3.Y[.]EH8R)YCXDA_DX M_P!U_G<7]Y_#_,_FRXXO,:OMR4P8XQP#^=_'_P`<_P!E_FO,-3UW6]5]/]*: MA:O,NB\1I6IW-G&LHG]"*5A$T@I\3Q5]-Z\5#M>3O^\ND50:PD.>,9G]%8'CXR\FY>KR58^W]F,&G&*>0R_>< M/#E^K'X.+^OZ?J\/C\3B]']#^+FNVLN7CC"O1?H_C\2?]7_.X>#^+^DP^;\N M;U]/#G3=0BU6[G1XH[:ROWL[:!Z3#XV6?\,\7!D\/U_P`S)#3\/%Q?T(Z\Z"7#],^.1_AAD\.$?YL^ M*''Z?YT/&_WR?_D_^7K3>83J.IZ?;:SH(BEBM[N.:WN+=9R%9&E@9Q**Q%OW M4T'JQO)'ZD,;?%'@=O\`:W#AX(2EAS6#*'#/'DX/Z&3AX/K_`(X9."7!+AG+ M^+*[*T-Y.*0CDQ_SKC*/%_2A]7T_PRAQ?T4N_,W\M]0L_.=Q^B]/6WTO4&9M M*@A/JO*\=L)IEBMH?5N`OJ!U_N5@BYIR:*'CF1V-VO">F'B2XLF/^]E+T\/% MDX,?'EGP8_I_I^)/U?7-J[1[/E',>$5"?T?Z7BEPPCQ3_P!CP1_HQ0-UH">7 M8+._M=,G>YF9[%SYCLVMHA/.#Z<\43AK%%B0$5NKV?\`>N7^HX,?I]'BRE/A:I8/"`D(FSZ/\(AP> MJ7\<8_W7I_VS+/\`G>'Z7IGY"^9/,6K:??VEW"OZ&L&5=/EK+6+G4_58V?U/ M5BA2G'G-ZL*M&G[Q'3TN:]I]'AQ3C*)_>Y/[SZ?5_MTN'AX)S_HPX,GJ^F4? M7N>Q=1DG$@CT1^CG_P`J_P"E&/\`6XH_[GJVPTTK]2UBSN;F6,K) MS1[.['H@.\CU407ZPM\/Q?5UE^U(^8^OU\M9@XY_7AG"'3_+8_7_``Q_RFF\ M3_DKP?PQ;M+I1I\O#'ZKA]/J]3+-AQ8Y1(C&`,I1GM&/H\/ M)]?]!WE^UTS1M;TORUH\TOU'2[&_BN879S6X]2PG#O4!7?(!QY?[)F&:=V#L5=BKL5=BKL5=BKL5=BK_`/_2]4XJ[%78J[%78J[%78J\WT;4 MKSR3IVE:?J5HIO=:U#3;"*W,\8=4&FVEM-,`GJ5H7TO7_,#:B5MD2`74DDCJ$6"75-5G21FKQ5?2=7-3\'[>8NMEXN+'P> MKU<'^?'3Z3'P_P"G]+?IAP9)\7IVXO\`-\7//_&*./\`F>-Q\.3P>'^?X<^'ZG"AV@`3FE'ZH\.'^=DABE/C_G>'_!XG M]7BBBM*\]Z1<>?+?6M+EB_0FNVUCI^H)Q"W"ZC*]W]6,JHCL71;=K9JR*O": M&7E)"B-E6?LS)'2G%,'Q<$LN7'_J?Y>'@^+P>J/I_>>+]/\`!.'IR,\>M@9_P!R^E:I+\-CI%S->ZA-U].W2PND M9^(^)_BD0<45G_R M1)O*&KVGFB[TOS3IULL$$MG?0ZF@:,O'>/)9JJ2<3R=C%;?`[+_<+%R]/DB9 MF:_!+31G@F>(B>.6+ZO5AX<_T_Y^7U1_U3C^KU./I,4<7JA4?BWPHW*3XU_O/AY9NI]EZ3%,Z@Q]4>++*? MKE_3E/@O_.^G^JZ^.MU$XC$)>F58^'T_U>'B9-90_6/.&G>3]`U3ZUIL>D:C MID%UZ]8+B6X@N9)I'CCKZ2?6N("$2,T5O;SJTR>B^:S)+AT\M3FAPY/&Q9I1 MX?7CACGBCCCQ2^N7@_U?7ER8_1ZXN9`7FCAQRXH^'DQ\5^F/Q(?[7']WW_5Z?%C_`!0EZ?Y_$6^<_//F:]^L^7)-:EU'1;.4 M0)*3$?K/U;X!,TL:JTJ2LOK(LDDO['.2:1/6S([.[,P0K,,8QY9CB_B_=>)Z MN#@F?1*'T>F,/XO3",N!JU>LR2O&9<>./N]?!_%Q?Q<7U?Q?YWU/5_R'\EZU MHNGW&L7TJI;:S!;RVMHC*Q*#FRR2_!\+<'4Q*DOV9']9/4X\.5]I^T<6:8QP M'JPRD)3_`-+Z8;_Z?BA_#Z/3]6\[%TD\<3.7+((\,?\`BO\`>^K^L]6SE7>. MQ5V*NQ5V*NQ5V*NQ5V*O_]3U3BKL5=BKL5=BKL5=BJR>""X@DM[B-9H)E,2XOK6H_O5CL;R3^ MX];9)K.4-#PGM:\HC&&WKQCZ^#_)YX>O]WF_C M\*,/YG]W.3H,_9'A^O#ZI?S9_P`/%_%BEZ?7C_AX^+^=]<7GNG>0_./E_4KA MM2T+4'>33[R*W%C`+Q&DN[>2V0220N4C5?49VW>3X5_=?O.6=!F[3TV>`X,F M/^\QREXDO!].*<F;F13-6&"-Y'7CQE=E]-5X%]/A\NQ5V*NQ5V*NQ5V*NQ5V*NQ5__5+-"_ M-3\^KK\J]0_,U?-T%Q;:%JL5G>Z'7[2J/\`S`UC\W?RX\K0RW7G:QUR_P#,&JV>CV>I:GIT&G6^ MF+/#=)8HDB;]S)SQ5)?S:UW\\/RS_`"WM]7O_`#NFJ:U? MZC96U8M-LHH[9?JMU)<1HQC/UA))%AXRO#"_[G[*>JZ8JJZM^=/G'\I_.-YY M:_,'5(/--E-I4FJ:+J<-H+*X>X(*PVDZP(2+#5O^5GP>>/1U5[']):-Y5TZW>2S>SGA^L+"82#')=".:2.%9;6 M\D:1+?\`TS[,D*J0>8O^_,?S#H_G/\`*RU\M:HBZ+YIU$1:@T20 M7$=U:O/9JA25UDHC1W$G&2!UY<^7+[.*I+^3OFS\W?S2OKWS@OF6#R_Y4M-5 MCMXO+4-E!=M+#"L9TAMT2*/%45Y7'YR^=M4\W MW.G_`)A?H*PT;S'J.CVEA^A[&\I#:NK1GU7]-_L2!/BY-\'+G\6*O3]=\S6O MD;R&^M^:;Y[Y=(M81J-]%`$DNI_@AY)`AX1OW2.T M<:<6BEBMEB2%4N$B:6%'E^W*K*LZ_-[\Q_,.C^<_RLM?+6J(NB^:=1$6H-$D M%Q'=6KSV:H4E=9*(T=Q)QD@=>7/ER^SBK$/R6U/\]/S,\K76O?\`*Q_T3]6O MI+'ZM^A=/N>7IPQ2\^=(:5];CQX_L_:Q5-?/UK^>GE+_``Y_R$[Z[_B#7++0 M_P#CAZ?%Z/UWG^__`-V>IZ?I_P!W\'+_`'XN*IA=_F-YA_+[SO-IOG?S$^MZ M+I/E)M7OKB*Q@MY+B]EU@VT!2*$?`YCDBM%7UE@_W=+Z?QR*JA/*/_0Q7Y@1 MKYKC\T6ODORSJR/<:3I2:?%?7448?TX1(+J&'FDT:FX^L?66]3FCQ01Q2\(E M4+^7WF'\X?S9DU_S+H7G1/*OEF#47LM'T[]%6EY/Z<:*]9O5/P.8Y(6>EQ/R MF:;@L421\E7T%BKL5?_6@7Y?^1]4U?\`)F;S.!^FM!\L:Y>7FM>3KB=[2WNK M=;&V]6YCG@,4JW4$7/AZCR)P_N8^7K6]\JR_\X_^5>_F!^>?DU]0UQ+;R;J^ M@"5]:BGBME54DOW0&2X5DB?UXUADCE3FK\H65)<59?H?Y:?\XPZ5Y%WCA@]2 M1,5>D_F1^2GGRZ\G^>O//G:^M=;\VO:QC2[.R_WCL-/MKF&ZG:!KE8WC>.". M=42/X_3]?G)=7%X_%5ZIY>_.CR'9_DUIOG2[NK6VL;:U@M;C3]/3@(]02%0^ MGVULQ#*ZL*0Q,>"V_&?U/JO[_%7S%^2WD2.'\T_(]EK4;RVGFS1]1NKFRE1[ M=A:W-MJ-H$#!@[)/!")XYD]/X)U]/_?C*I_YMTWS/Y7_`#K_`"\\@:G>OJ6@ MZ!K%E<^5;ZYX&Z.GWUW;J(9&1CR2VDM7@BY)&_P-P1+;ZO%$JFOYC6GDSR%Y MGTWSS^2_F*UN?,&H:BMG<^4].G@OH)H[I"WIQVULWK+;R31<6@^/][/#]4:U M:"#%5+3?RR_)GS3YI\]ZAYW\U_H+58O-6K6\%I^D+&SY6ZS!UD].YC>0UD>5 M>8/#X/\`);%7I/Y]?E[^E_R"TK2_*;SZO#Y?_1L^DQVL?UV:^MXXOJ:%3;T# M?N;CZRTL4;(RQ_85&Y(JI?FU^>'E+6OR/U'5/*/F=+'7+I+1[.SBNUM=5B;Z M[")HS"D@G5U02B3AR1XN3H\D#3:)Y!_*WS;^:7YF?X[\Q_X?^I:YI)/4]/TXO[O[//XOM+BK(+;R9Y(MOSW_+[RGHM[^G?*4_ MES4K477UB.;UX;K],?6%]>U$:?;DEBY1<63C_.N*I5YOT/SCY5_.#\N/)FJS MSZAY7T;7+5_*&K72CUGL[FYM.=LTJ$H_U)XEB52L0UD>5>8/#X/\EL5 M>_?FA8:7IWE;\H=/TBY^N:59^:O+MOI]WS27UK>*&1(I/4C`C?G&%;F@X-^S MBK%?SZ\M:IYE_,?S)I&E1^M?R>0([B&`!V:3ZIKT=RT<:QJ[O+(D+)"@7XY6 M1?A^UBK-/R:_.7\L[C\L_+UM<^8;'2[W2[&VTV\L]2N8;299K2%(F95E<;M.7S)+=.-9T."\^OQZB+N1I MIF:.)Y6C1FKZR.T5O\,3VTEM=Q0^NJ]N\P_GO^5WER^GL=PN;>>2UD$V MGZB%,T2H[JD@MS')2.:&3E&S*T4T,J_NY8V95GV*O__7[7^2W_*J/\+77_*L M?^.#]>D^L_[V?[V>C%S_`-[?WO\`=>C]G]W_`++GBKR"\_Z$@^KV'J^AZ?H- M]7]'],\^'KRU]?TOWGJ^ISI]9_?^AZ/'_1OJ^*H7_K!?_/\`Q!BK/]?_`.A8 MO^56Z=]=^H_X"^O0_5OJ'UK_`(Z'U1N'UGZE_I7UKZK7UOK?[[[/UC]YPQ5[ M1BKYWU+_`*$Q_P`8I]8_17Z5]>WX_5OKGZ+YT3TZ_5_]Q/I?9]?E^X_O/K/^ M[<5>E:S_`,JH_P"5QZ%^DO\`R9/U%_T)_O9_O'QN>?V/]"^S];_OOWG_`"2Q M5%>=/^58_P",?)_^+/0_Q%Z]S_A'ZSZO#ZQ2+U:4_P!&]7EZ'H?6/C]?T_JO M[_%6`?E%_P!"M?XQC_Y5]Z'^)_0E^J^M^D>?"@]7T/TA^[]7T^5?1_?^AZW^ MZ?6Q5(/-G_0FG^*=9_Q!_P`=[Z]<_I?_`([G^]GK-]8_N?W7][S_`+K]W_)\ M.*O??*?Z"_PMHW^'_P#C@_4;;]$?WG^\?HK]7_OOWO\`=KZGK>O_`*5]GU/A]/%4 MJ\V?]":?XIUG_$'_`!WOKUS^E_\`CN?[V>LWUC^Y_=?WO/\`NOW?\GPXJRKR M/_T+=_BGR?\`X6_X[WU&Z_PG_P`=3_>/UKWZQ_?_`+K^]_2'^]/[S_??P^AB MK/\`S?\`\JY_3OE?_%7U'],_7F_PM];X^K]<],U]&O\`L/M_N_K7U3_CZ^J8 MJ\!_ZP7_`,_\08J]IU+_`)51_A;R)]=_XX/U[2?\$?[V?[V>B?T;]G][_=5_ MWK_=_P#+1\6*IK_SHO\`RM+_`+_W]!_\O'_'(^M_](O^]7_1Q_SSQ5YK^9__ M`$*=^E!_B_\`17Z5]>Y^L_HWZQ]8^L?"@]7T/TA^[]7T^5?1_?^AZW^Z?6Q5% M_FS_`-"W?I%O^5A?[V_7I^7_`!U/][/J-AZW^\GP_P"\7Z-_XK_E_>_6,5>T $8J__V3\_ ` end -----END PRIVACY-ENHANCED MESSAGE-----